| Name | Title | Contact Details |
|---|
Dan Toomey Software is a Norwell, MA-based company in the Software and Internet sector.
enChoice is a leading provider of end-to-end enterprise content management (ECM) solutions and services.
Prove is the modern way for businesses to enable their customers to prove their identities. Prove offers phone-centric solutions that enable its customers to acquire new consumers and engage with their existing consumers by removing friction while bolstering security and enhancing consumer privacy & consumer choice. Prove`s solutions are used by more than 1,000 businesses across diversified industries, including banks, financial services, healthcare, insurance, and e-commerce. With 1 billion+ consumer and small business identity tokens under continuous management, Prove`s Phone-Centric Identity™ platform helps companies mitigate fraud while accelerating revenue and reducing operating costs across all channels. Prove`s omnichannel solutions are available in 195 countries.
Phillip Hauptman is a Lincoln, NE-based company in the Software and Internet sector.
Intelisys Health shifts the paradigm of medication pricing by aligning the needs of patients, providers and payors within the industry’s first real-time prescription transparency platform. Powered by the union of actionable data and predictive analytics, the ground-breaking technology delivers the lowest prescription costs while offering new opportunities for improved medication adherence and compliance. By connecting disparate data and stakeholders across the care continuum, Intelisys Health empowers providers and patients with an intelligent, transparent view of prescription drug pricing, drug fills and refills, and alternative drug therapies within one second or less at the point of care and within the e-Prescribing workflow. The analytics-driven platform drives maximum cost savings, workflow efficiencies, patient safety and health outcomes while successfully addressing the new landscape of shared risk payment models, cost containment and outcomes-based reimbursements.